You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Skip to main navigation
Skip to main content
Turn on more accessible mode
Turn off more accessible mode
Sign In
This site uses cookies to help us give you the best experience on our website. To find out more about the cookies we use, read our
Terms and Conditions
Hide This
Search
Advanced Search
Sign up to e-alerts
Home
Currently selected
About us
Who we are and what we do
The Code
Interactive Code 2016
Interactive Code 2015
Interactive Code 2014
Advice
Appeal Procedures
Supply of emollients for patients to try
Third party service providers, ABPI membership and the Code
Cases
Ongoing cases
Completed cases
Code of Practice Reviews
Corrective statements
Advertisements and public reprimands
Media
News archive
Training
News articles
Currently selected
Advanced Search
Sign up to e-alerts
Search
Home
Currently selected
About us
The Code
Advice
Cases
Media
Training
Contact Us
Site Map
Sign up to e-alerts
PMCPA
>
News articles
News articles
Currently selected
E-learning module for health professionals
Read more
News articles
Page Content
UCB and PharmaMar have been named in advertisements following breaches of the ABPI Code of Practice and PharmaMar has been publicly reprimanded and required to issue a corrective statement.
Press Release
Read more
Signatories
Read more
Guidance on Appeal Procedures
Guidance on Appeal Procedures January 2016
Read more
Joint Letter from ABPI and NHS England about Disclosure
Read more
Sunovion Pharmaceuticals Europe Ltd, Bayer plc, Astellas UK Limited, Astellas Pharma Europe Limited and A Menarini Pharma UK SRL have been named in advertisements(1) following breaches of the ABPI Code of Practice and Sunovion was publicly reprimanded.
Press Release
Read more
PMCPA Annual Report 2016 Press Release
Read more
Astellas UK, Astellas Europe, Pfizer, Novartis Pharmaceuticals and Tor Generics named in advertisements following breaches
Press Release
Read more
Disclosure of Payments to Healthcare Professionals (HCPS), Other Relevant Decision Makers (ORDMS) And Healthcare Organisations (HCOS) - 2016 data now disclosed
Read more
Astellas UK’s suspension from membership of the ABPI extended
Astellas UK was suspended from membership of the Association of the British Pharmaceutical Industry (ABPI) with effect from 24 June 2016. This has been extended for a further 12 months.
Read more
Clinical Trial Disclosure - Decision Tree May 2017
As a result of a number of cases considered in 2016, the decision tree published in previous case reports has been updated and included in recent case reports. It is available in the link below and in the Code of Practice Review, May 2017.
Read more
Page Content 2
